Interleukin 17 and Treg – A Common Pathomechanism and a New Target of Therapy in Rheumatic Diseases and Depression

Reumatologia - Poland
doi 10.5114/reum.2018.77969
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Pain, Catastrophizing, and Depression in the Rheumatic Diseases

Nature Reviews Rheumatology
Rheumatology
2011English

Il-23/Il-17 Inhibitors in Immunoinflammatory Rheumatic Diseases: New Horizons

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

The Role of Interleukin-4 in Rheumatic Diseases

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

The Common Inflammatory Etiology of Depression and Cognitive Impairment: A Therapeutic Target

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Treg/Il-17 Ratio and Treg Differentiation in Patients With COPD

PLoS ONE
Multidisciplinary
2014English

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon

Balkan Medical Journal
Medicine
2020English

Clinics in Rheumatic Diseases. Immunogenetics and Rheumatic Disease

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1978English

The Thymus Is a Common Target Organ in Infectious Diseases

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2006English

Surgery and Rheumatic Diseases

BMJ
1939English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy